Literature DB >> 21380610

Summary of confirmation cut point discussions.

Holly W Smith1, Michael Moxness, Robin Marsden.   

Abstract

A subgroup of AAPS NBC Immunogenicity Workshop attendees met to discuss the current recommendations in white papers and guidance documents, to describe and discuss current practices, and to resolve concerns as to the biologically and statistically appropriate approaches to determining a confirmatory cut point for immunogenicity assays. This is a summary of our discussions and recommendations.

Mesh:

Substances:

Year:  2011        PMID: 21380610      PMCID: PMC3085706          DOI: 10.1208/s12248-011-9263-z

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  4 in total

1.  Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products.

Authors:  Anthony R Mire-Sluis; Yu Chen Barrett; Viswanath Devanarayan; Eugene Koren; Hank Liu; Mauricio Maia; Thomas Parish; George Scott; Gopi Shankar; Elizabeth Shores; Steven J Swanson; Gary Taniguchi; Daniel Wierda; Linda A Zuckerman
Journal:  J Immunol Methods       Date:  2004-06       Impact factor: 2.303

Review 2.  Assessing specificity for immunogenicity assays.

Authors:  Steven J Swanson; Narendra Chirmule
Journal:  Bioanalysis       Date:  2009-06       Impact factor: 2.681

Review 3.  Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products.

Authors:  Eugen Koren; Holly W Smith; Elizabeth Shores; Gopi Shankar; Deborah Finco-Kent; Bonita Rup; Yu-Chen Barrett; Viswanath Devanarayan; Boris Gorovits; Shalini Gupta; Thomas Parish; Valerie Quarmby; Michael Moxness; Steven J Swanson; Gary Taniguchi; Linda A Zuckerman; Christopher C Stebbins; Anthony Mire-Sluis
Journal:  J Immunol Methods       Date:  2008-01-29       Impact factor: 2.303

Review 4.  Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products.

Authors:  Gopi Shankar; Viswanath Devanarayan; Lakshmi Amaravadi; Yu Chen Barrett; Ronald Bowsher; Deborah Finco-Kent; Michele Fiscella; Boris Gorovits; Susan Kirschner; Michael Moxness; Thomas Parish; Valerie Quarmby; Holly Smith; Wendell Smith; Linda A Zuckerman; Eugen Koren
Journal:  J Pharm Biomed Anal       Date:  2008-09-19       Impact factor: 3.935

  4 in total
  3 in total

1.  Statistical and bioanalytical considerations for establishing a depletion criterion for specificity testing during immunogenicity assessment of a biotherapeutic.

Authors:  R O Driscoll; L Zhou; M Moxness; D Mytych; N Chirmule; V Jawa
Journal:  AAPS J       Date:  2013-08-30       Impact factor: 4.009

2.  Recommendations for Systematic Statistical Computation of Immunogenicity Cut Points.

Authors:  Viswanath Devanarayan; Wendell C Smith; Rocco L Brunelle; Mary E Seger; Kim Krug; Ronald R Bowsher
Journal:  AAPS J       Date:  2017-07-21       Impact factor: 4.009

3.  Immunogenicity Assessment of Lipegfilgrastim in Patients with Breast Cancer Receiving Chemotherapy.

Authors:  Linglong Zou; Anton Buchner; Martin Roberge; Patrick M Liu
Journal:  J Immunol Res       Date:  2016-06-23       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.